Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ONT-10 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
ONT-10 is a cancer vaccine that consists of encapsulated glycoprotein MUC1 and the synthetic Toll-like receptor 4 (TLR-4) agonist PET lipid A, which may lead to immune stimulation and antitumor effects (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C101262 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ONT-10 | ONT-10 | 0 | 1 |